Скачать или смотреть The Future of Adjuvant PARP Therapy: MRD, ADCs, and Beyond

What’s next for PARP inhibitors in early breast cancer? Drs. Iyengar and Robson look ahead to how MRD testing, novel ADCs, and genomic evolution may reshape adjuvant therapy for BRCA-mutated disease in the years to come.

🔔 Subscribe for more expert-level oncology updates and stream the full conversation today.

#PARPInhibitors #Olaparib #MRDTesting #ADCs #BreastCancer #BRCA #OncologyPodcast #CommunityHealthMedia #PrecisionOncology

–

Thanks for watching!

Our podcasts are also available on:
• Spotify - https://spotf.fi/chm-podcast
• Amazon Music - https://amazn.so/chm-podcast
• Apple Podcast - https://podcasts.apple.com/us/podcast...
• Castbox - https://castbox.fm/vh/6735434
• Goodpods - https://goodpods.com/profile/chm-111066
• iHeartRadio - https://iheart.com/podcast/291542082
• Pocket Casts - https://pca.st/3ncdh11o

–

Community Health Media (CHM) is your full service healthcare communications partner, combining our production expertise with targeted multi-channel campaigns. We connect companies and healthcare brands with key opinion leaders, patients, and consumers through compelling content and live experiences.

We’re an integrated marketing company that produces world-class content and curated peer to peer live experiences.

We specialize in:
• Peer to peer interviews, panels & round-tables
• Curated live events & conferences
• Professional in-depth content & research updates
• Interactive learning modules & webinars
• Live & on-demand webcasts & podcasts

Learn more about us here - https://communityhealth.media